View Older Stories View More Recent Stories
-
Form 13F-HR Broadfin Capital, LLC For: Sep 30
-
Form SC 13D/A CARDICA INC Filed by: Broadfin Capital, LLC
-
Form SC 13G Aegerion Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Form SC 13G TITAN PHARMACEUTICALS Filed by: Broadfin Capital, LLC
-
PlacementTracker Publishes Third Quarter 2014 PIPE Market League Tables
-
Broadfin Capital Raises Stake in Anthera Pharmaceuticals (ANTH) to 5.7%
-
Form SC 13G Anthera Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Form SC 13G Recro Pharma, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13D/A CARDICA INC Filed by: Broadfin Capital, LLC
-
Form 13F-HR Broadfin Capital, LLC For: Jun 30
-
Alliqua Biomedical, Inc. Reports Second Quarter 2014 Financial Results
-
Form SC 13G Biota Pharmaceuticals, Filed by: Broadfin Capital, LLC
-
Broadfin Capital Shows 9.98% Stake in Cardica, Inc. (CRDC) - 13D
-
Form SC 13D CARDICA INC Filed by: Broadfin Capital, LLC
-
PlacementTracker Publishes First Half 2014 PIPE Market League Tables
-
Broadfin Capital Moves Stake in Oxygen Biotherapeutics (OXBT) to 5.45%
-
PlacementTracker Publishes First Quarter 2014 PIPE Market League Tables
-
Universal American (UAM) Plans 6M Common Buyback from Capital Z Partners
-
Broadfin Capital Shows New 8.1% Stake in (REPH)
-
Broadfin Capital Shows New 9.42% Stake in Pernix Therapeutics (PTX)
-
Broadfin Capital Shows New 16.1% Stake in MELA Sciences (MELA)
-
MELA Sciences (MELA) Enters $12.45M Private Placement
-
PlacementTracker Publishes 2013 PIPE Market League Tables
-
Broadfin Capital Raises Stake in Derma Science (DSCI) to 5.04%
-
Flamel Tech (FLML) Enters $15M Secured Financing Arrangement
-
Broadfin Capital Shows New 5.8% Stake in Discovery Laboratories (DSCO)
-
Pharming announces EU12.0 million private equity placement with institutional investors
-
Notable 52-Week Highs and Lows of the Day 10/04: (IDRA) (YHOO) (MHR) High; (JCP) (CVM) (HCP) Low
-
Unusual 11 Mid-Day Movers 10/04: (DSCO) (IDRA) (GALT) Higher; (CVM) (BLDP) (LCI) Lower
-
Broadfin Capital Shows New 7.68% Stake in Idera Pharmaceuticals, Inc. (IDRA)

